The medical landscape is witnessing a development with the arrival of GLP-1 delivery devices. These exciting formulations offer a potential alternative to delivering glucagon-like peptide-1 therapies for individuals managing type 2 diabetes . Instead of needles, a convenient patch applied to the area could release a steady quantity of the treatment